Q4 met the street's expectations
07/02/25 -"GN’s Q4 results met market expectations. Healthy growth in the Hearing segment was counterbalanced by a weaker performance in Gaming & Consumer and Enterprise. For 2025, management expects ..."
Pages
61
Language
English
Published on
07/02/25
You may also be interested by these reports :
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...
05/02/26
GN’s Q4 results fell short of market expectations. While Hearing experienced healthy growth, this was overshadowed by weaknesses in Gaming and ...
05/02/26
Our estimates have been moderated following the Q4 25 miss, primarily reflecting a softer order book and growth momentum (especially for the LS ...